August 04th, 2023

AMC Networks Inc. (Nasdaq: AMCX) reported Q2 2023 adjusted earnings per share (EPS) of $2.02, surpassing analysts' expectations of $1.60.  However, the company reported quarterly revenues of $678.63 million, falling short of the consensus est. Read more

August 04th, 2023

Fluor Corporation (NYSE: FLR) has reported adjusted earnings per share (EPS) of $0.76 for the second quarter of 2023, with revenues totaling $3.94 billion. These results significantly surpassed the consensus estimate of $0.43 EPS on revenues of $3.68. Read more

August 04th, 2023

Mesoblast Limited (Nasdaq: MESO) has announced the receipt of a comprehensive response from the US Food and Drug Administration (FDA) regarding its Biologics License Application (BLA) resubmission for remestemcel-L. The FDA's response stipulates the . Read more

August 03rd, 2023

Shares of Booking Holdings Inc. (Nasdaq: BKNG) experienced a remarkable after-hours surge of over 10% following the release of its second-quarter 2023 financial results. The company outperformed expectations with an earnings per share (EPS) of $37. Read more

August 03rd, 2023

FOR IMMEDIATE RELEASE 2023-146 Washington D.C. / CRWE PRESS RELEASE / Aug. 3, 2023 -  The Securities and Exchange Commission today announced that it obtained a temporary asset freeze, restraining order, and other emergency relief agains. Read more

August 03rd, 2023

NeuBase Therapeutics, Inc. (Nasdaq: NBSE) announced a pause in its program development. Instead, NeuBase will explore strategic options, including acquisitions, mergers, and other transactions, with the goal of maximizing shareholder value. Accord. Read more

August 03rd, 2023

Shares of Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) surged over 5% in pre-market trading following an impressive second quarter 2023 earnings report. The company exceeded expectations, reporting adjusted earnings per share (EPS) of $10.24 and re. Read more

August 03rd, 2023

Murphy Oil Corporation (NYSE: MUR) announced its second quarter 2023 financial results, revealing adjusted earnings per share (EPS) of $0.79 and revenues of $814.59 million. The company's performance exceeded the consensus estimate of $0.78 on revenu. Read more

August 03rd, 2023

Shares of Equillium, Inc. (Nasdaq: EQ) surged in the extended session after the company announced an up to $7.5 million stock buyback program. $EQ was trading at $0.96 in after-hours, up $0.21 (+28.01%) In other news, Upwork Inc. (Nasdaq: UPWK). Read more

August 02nd, 2023

CVS Health Corporation (NYSE: CVS) announced second quarter 2023 adjusted earnings per share (EPS) of $2.21 and recorded revenues of $88.92 billion, surpassing the consensus EPS estimate of $2.11 on revenues of $86.45 billion. The company confirme. Read more